Surgery Partners Inc. (SGRY)
NASDAQ: SGRY
· Real-Time Price · USD
23.61
0.81 (3.55%)
At close: May 30, 2025, 3:59 PM
23.61
0.01%
After-hours: May 30, 2025, 04:21 PM EDT
Surgery Partners Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Government Revenue Revenue | 1.26B | 1.13B | 1.06B | 949.9M | 708.5M | 701.9M | 24.94M | 8.33M | 4.61M |
| Government Revenue Revenue Growth | +11.41% | +6.50% | +11.51% | +34.07% | +0.94% | +2714.81% | +199.39% | +80.75% | n/a |
| Healthcare Organization, Patient Service Revenue | 3.05B | 2.7B | 2.5B | 2.19B | 1.84B | 1.8B | n/a | n/a | n/a |
| Healthcare Organization, Patient Service Revenue Growth | +13.11% | +7.93% | +13.99% | +19.55% | +1.83% | n/a | n/a | n/a | n/a |
| Other Patient Service Revenue Sources Revenue | 81.1M | 85.6M | 89M | 73.9M | 79.2M | 84.6M | n/a | n/a | n/a |
| Other Patient Service Revenue Sources Revenue Growth | -5.26% | -3.82% | +20.43% | -6.69% | -6.38% | n/a | n/a | n/a | n/a |
| Other Services Revenue | 59.9M | 42.9M | 37.2M | 30.1M | 21M | 24.5M | n/a | n/a | n/a |
| Other Services Revenue Growth | +39.63% | +15.32% | +23.59% | +43.33% | -14.29% | n/a | n/a | n/a | n/a |
| Private Insurance Revenue | 1.63B | 1.42B | 1.29B | 1.11B | 989.9M | 970.5M | n/a | n/a | n/a |
| Private Insurance Revenue Growth | +15.20% | +10.14% | +16.03% | +12.14% | +2.00% | n/a | n/a | n/a | n/a |
| Self-Pay Revenue Revenue | 82.3M | 68.1M | 65.9M | 61.1M | 58.5M | 46.1M | n/a | n/a | n/a |
| Self-Pay Revenue Revenue Growth | +20.85% | +3.34% | +7.86% | +4.44% | +26.90% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 |
|---|---|
| Idaho Revenue | 17.2M |
| Idaho Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 36M | 36M | 120.2M | 40.3M | 33.2M | 20.9M | 109.2M | 31.2M | 32M | 28.7M | 17.9M | 26.1M | 29.5M | 27.2M | 25.5M | 24.5M | 26.8M | 23.8M | 25.2M | 25.3M | 22.8M | 23.7M | 19.9M | 23.3M | 21.7M | 23.83M | 19.48M | 26.1M | 24.15M | 21.38M | n/a | 18.66M | 15.54M | 18.04M | 14.98M | 15.02M | 12.2M | 21.05M | 11.24M | 11.85M | 11.86M |
| Selling, General, and Administrative Revenue Growth | 0.00% | -70.05% | +198.26% | +21.39% | +58.85% | -80.86% | +250.00% | -2.50% | +11.50% | +60.34% | -31.42% | -11.53% | +8.46% | +6.67% | +4.08% | -8.58% | +12.61% | -5.56% | -0.40% | +10.96% | -3.80% | +19.10% | -14.59% | +7.37% | -8.93% | +22.34% | -25.37% | +8.06% | +12.99% | n/a | -100.00% | +20.04% | -13.86% | +20.39% | -0.25% | +23.17% | -42.05% | +87.33% | -5.15% | -0.13% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |